NACDS Total Store Expo 2019 Coverage Is Coming
Stay tuned for upcoming coverage on the NACDS Total Store Expo in Boston, MA, August 24-26.
Pharmacy Times will be on location in Boston next week to deliver coverage on the National Association of Chain Drug Stores’ Total Store Expo (NACDS TSE).
The meeting aims to give industry leaders new insights into the industry and evolving marketplace, so that owners and employees can chart a successful course for their companies.
Here are some sessions to watch for in our upcoming coverage of this year’s NACDS TSE:
- Community Pharmacy-Based Point-of-Care Testing—This session will provide pharmacists with the chance to earn a certificate of completion and will explain practical ways for them to implement the NACDS Point-of-Care Testing (POCT) program in their own organizations.
- NACDS Institute Exploring Specialty Drugs and Care Services in Community Pharmacy—As community pharmacies increasingly offer specialized services to their patients, innovative specialty drugs require increasingly high touch interactions with patients to manage their therapies. This session will cover an analysis of the specialty drug and pharmacy market, and will also examine specific opportunities for pharmacies to get a foothold in the specialty market.
- Community Pharmacy’s Role in Optimizing Medication Use and Quality for Patients with Chronic Disease—Community pharmacy is uniquely positioned to improve medication use and quality in health care, and this session will examine how pharmacists can fully realize their potential in this space. Topics covered will include chronic care management, quality metrics, and more.
In addition to these exciting sessions, stay tuned for interviews with leaders in the field as they discuss topics such as the future of CBD, technology and the future of pharmacy, and opportunities for chain pharmacy in preventive care. Keep an eye out for updates on PharmacyTimes.com, in our daily e-newsletters, and on our social media channels: Facebook, Twitter, Instagram, and LinkedIn.